OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutramine had a greater weight loss than that using placebo (6.7% versus 2.5%; p<0.001), an increase in heart rate (78.3±7.3 to 82±7.9 bpm; p=0.02), and a reduction in the left ventricular mass/height index (105±29.3 versus 96.6±28.58 g/m; p=0.002). Both ...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
Objective: the objective of this study is to assess the effects of sibutramine on body weight, body ...
OBJECTIVE: Sibutramine, a serotonin and norepinephrine transporter inhibitor, is widely used as a...
Background: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
Obesity and hypertension are closely associated risk factors for cardiovascular disease. An increase...
OBJECTIVE: Sibutramine causes weight loss by suppressing the appetite and by promoting energy expend...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
CONTEXT: Systemic arterial hypertension is part of the metabolic syndrome resulting from obesity. OB...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
Objective: the objective of this study is to assess the effects of sibutramine on body weight, body ...
OBJECTIVE: Sibutramine, a serotonin and norepinephrine transporter inhibitor, is widely used as a...
Background: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
Obesity and hypertension are closely associated risk factors for cardiovascular disease. An increase...
OBJECTIVE: Sibutramine causes weight loss by suppressing the appetite and by promoting energy expend...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
CONTEXT: Systemic arterial hypertension is part of the metabolic syndrome resulting from obesity. OB...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...